Cargando…

False‐positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy

A positive nuclear scintigraphy with hydroxy bisphosphonate bone tracer (99mTc‐HPD) is believed to have high sensitivity (>99%) and specificity (91%) for the diagnosis of transthyretin amyloid cardiomyopathy. We report the case of an 85‐year‐old man with increased thickness of ventricular walls a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chimenti, Cristina, Alfarano, Maria, Maestrini, Viviana, Galea, Nicola, De Vincentis, Giuseppe, Verardo, Romina, Fedele, Francesco, Frustaci, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318478/ https://www.ncbi.nlm.nih.gov/pubmed/34032384 http://dx.doi.org/10.1002/ehf2.13339

Ejemplares similares

Removal of cardiac AL amyloid with positive remodelling of cardiomyocytes and of restrictive cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2022)

Immune‐Mediated Myocarditis in Fabry Disease Cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2018)

Inflammation of Conduction Tissue in Patients with Arrhythmic Phenotype of Myocarditis
por: Frustaci, Andrea, et al.
Publicado: (2020)

Pemphigus‐associated cardiomyopathy: report of autoimmune myocarditis and review of literature
por: Frustaci, Andrea, et al.
Publicado: (2021)

Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
por: Chimenti, Cristina, et al.
Publicado: (2021)

Myocarditis and intramural coronary vasculitis in polyarteritis nodosa: an unusual treatable form of heart failure
por: Chimenti, Cristina, et al.
Publicado: (2020)

Infiltration of Conduction Tissue Is a Major Cause of Electrical Instability in Cardiac Amyloidosis
por: Frustaci, Andrea, et al.
Publicado: (2023)

Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement
por: Frustaci, Andrea, et al.
Publicado: (2022)

Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
por: Frustaci, Andrea, et al.
Publicado: (2023)

Myocarditis-associated necrotizing coronary vasculitis: incidence, cause, and outcome
por: Frustaci, Andrea, et al.
Publicado: (2020)

Biopsy-proven autoimmune myocarditis in HIV-associated dilated cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2014)

Novel dilated cardiomyopathy associated to Calreticulin and Myo7A gene mutation in Usher syndrome
por: Frustaci, Andrea, et al.
Publicado: (2021)

(99m)Technetium‐pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy
por: Tahara, Nobuhiro, et al.
Publicado: (2021)

Diagnosis of Transthyretin Amyloid Cardiomyopathy
por: Hafeez, Adam S., et al.
Publicado: (2020)

Hereditary transthyretin amyloid cardiomyopathy
por: Zheng, Yiliang, et al.
Publicado: (2023)

Interleukin-17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery following Secukinumab Administration
por: Frustaci, Andrea, et al.
Publicado: (2023)

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
por: Morfino, Paolo, et al.
Publicado: (2023)

Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
por: Rocha, Alexandre Marins, et al.
Publicado: (2017)

Systemic embolism in amyloid transthyretin cardiomyopathy
por: Vilches, Silvia, et al.
Publicado: (2022)

Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function
por: Nakano, Tomoya, et al.
Publicado: (2022)

Hypersensitivity Myocarditis after COVID-19 mRNA Vaccination
por: Frustaci, Andrea, et al.
Publicado: (2022)

Myocardial Aldosterone Receptor and Aquaporin 1 Up-Regulation Is Associated with Cardiomyocyte Remodeling in Human Heart Failure
por: Frustaci, Andrea, et al.
Publicado: (2021)

Multi-modality imaging in transthyretin amyloid cardiomyopathy
por: Traynor, Bryan Paul, et al.
Publicado: (2019)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
por: Fontana, Marianna, et al.
Publicado: (2023)

Infarct‐like myocarditis with coronary vasculitis and aneurysm formation caused by Epstein–Barr virus infection
por: Chimenti, Cristina, et al.
Publicado: (2020)

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
por: Nativi-Nicolau, Jose, et al.
Publicado: (2021)

Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy
por: Falk, Rodney H., et al.
Publicado: (2021)

Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery
por: Porcari, Aldostefano, et al.
Publicado: (2020)

Initial Experience With Tafamidis Treatment for Transthyretin Amyloid Cardiomyopathy
por: Nakamura, Makiko, et al.
Publicado: (2020)

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
por: Lauppe, Rosa Elisabeth, et al.
Publicado: (2021)

Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
por: Lauppe, Rosa, et al.
Publicado: (2022)

Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy
por: Nuvolone, Mario, et al.
Publicado: (2022)

Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy
por: Knoll, Katharina, et al.
Publicado: (2023)

Virus-Negative Necrotizing Coronary Vasculitis with Aneurysm Formation in Human SARS-CoV-2 Infection
por: Frustaci, Andrea, et al.
Publicado: (2021)

A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy
por: Chimenti, Cristina, et al.
Publicado: (2021)

Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
por: Li, Benjamin, et al.
Publicado: (2020)

Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
por: Bruno, Marianna, et al.
Publicado: (2020)

A Systematic Review of Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
por: Singh, Bishnu Mohan, et al.
Publicado: (2021)

Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
por: Elliott, Perry, et al.
Publicado: (2021)

Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges
por: Tschöpe, Carsten, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_61q4e1j5413vqp9bjo0sei961p